Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Craig Gulliford Insider Profile
4 Followers
Craig Gulliford, Chief Executive Officer at Creo Medical, holds 1.64M shares in Creo Medical (Ticker: GB:CREO).
Craig Gulliford Creo Medical (CREO)Chief Executive Officer
Creo Medical (CREO)
Chief Executive Officer
Ranked #47,945 out of 98,624 Corporate Insiders
Profitable Transactions
2 out of 3 Profitable Transactions
Average Return
+0.60%
Average return per transaction
Time Frame
Compare to
Insider Holdings
100.00%
A breakdown of Craig Gulliford's holdings
Insider Roles
Chief Executive Officer
Roles that Craig Gulliford holds in companies
Most Profitable Insider Trade
The most profitable trade made by Craig Gulliford
Craig Gulliford's Trading History
List of latest transactions for each holding click on a transaction to see Craig Gulliford's performance on stock
You May Also Like
Craig Gulliford insider profile FAQ
What is the percentage of profitable transactions made by Craig Gulliford?
The percentage of profitable transactions made by Craig Gulliford is 67%.
What is the average return per transaction made by Craig Gulliford?
The average return per transaction made by Craig Gulliford is 0.60%.
What stocks does Craig Gulliford hold?
Craig Gulliford holds: GB:CREO stocks.
What was Craig Gulliford’s latest transaction?
Craig Gulliford latest transaction was an Uninformative Buy of ―.
What was Craig Gulliford's most profitable transaction?
Craig Gulliford’s most profitable transaction was an Informative Sell of GB:CREO stock on August 31, 2018. The return on the trade was 21.00%.
What is Craig Gulliford's role in Creo Medical?
Craig Gulliford's role in Creo Medical is Chief Executive Officer.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.